WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+9.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$11.8B
AUM Growth
+$1.41B
(+13%)
Cap. Flow
+$896M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
744
New
202
Increased
220
Reduced
152
Closed
160
Top Buys
| 1 |
ASML
ASML
|
$125M |
| 2 |
Meta Platforms (Facebook)
META
|
$100M |
| 3 |
STMicroelectronics
STM
|
$92.5M |
| 4 |
MetLife
MET
|
$79.4M |
| 5 |
Gilead Sciences
GILD
|
$77.3M |
Top Sells
| 1 |
TE Connectivity
TEL
|
$161M |
| 2 |
Eli Lilly
LLY
|
$151M |
| 3 |
Marsh & McLennan
MMC
|
$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$86.7M |
| 5 |
Electronic Arts
EA
|
$78.6M |
Sector Composition
| 1 | Healthcare | 43.57% |
| 2 | Technology | 17.47% |
| 3 | Industrials | 8.1% |
| 4 | Energy | 6.42% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTV
401
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$88.2M
| $4.37M | 0.04% |
+283,124
| New | +$4.37M |
|
402
LGI Homes
LGIH
$1.55B
| $4.21M | 0.04% |
+35,524
| New | +$4.21M |
|
403
Kulicke & Soffa
KLIC
$1.99B
| $4.19M | 0.04% |
92,901
+28,284
| +44% | +$1.28M |
|
404
iShares US Real Estate ETF
IYR
$3.76B
| $4.19M | 0.04% |
+41,086
| New | +$4.19M |
|
405
Liquidia Corp
LQDA
$2.48B
| $4.15M | 0.03% |
+414,892
| New | +$4.15M |
|
|
RVNC
406
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.14M | 0.03% |
+797,953
| New | +$4.14M |
|
407
Birkenstock
BIRK
$9.23B
| $4.1M | 0.03% |
83,238
+374
| +0.5% | +$18.4K |
|
408
Tourmaline Bio
TRML
$687M
| $4.09M | 0.03% |
159,154
+1,207
| +0.8% | +$31K |
|
409
Aquestive Therapeutics
AQST
$656M
| $4.06M | 0.03% |
816,252
+215,293
| +36% | +$1.07M |
|
410
Neumora Therapeutics
NMRA
$272M
| $4.06M | 0.03% |
307,558
+143,398
| +87% | +$1.89M |
|
411
Honeywell
HON
$136B
| $4.06M | 0.03% |
+19,648
| New | +$4.06M |
|
412
JD.com
JD
$44.6B
| $4.06M | 0.03% |
+101,482
| New | +$4.06M |
|
413
Viking Therapeutics
VKTX
$3.03B
| $4.04M | 0.03% |
63,819
-1,607
| -2% | -$102K |
|
414
Clorox
CLX
$15.5B
| $3.96M | 0.03% |
24,338
+6,734
| +38% | +$1.1M |
|
415
Zentalis Pharmaceuticals
ZNTL
$126M
| $3.88M | 0.03% |
1,055,282
-461,795
| -30% | -$1.7M |
|
416
UroGen Pharma
URGN
$873M
| $3.88M | 0.03% |
305,642
+1,902
| +0.6% | +$24.2K |
|
|
RAPP
417
Rapport Therapeutics
RAPP
$524M
| $3.82M | 0.03% |
186,560
+15,460
| +9% | +$317K |
|
|
ONC
418
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $3.78M | 0.03% |
16,848
-28,230
| -63% | -$6.34M |
|
419
VSE Corp
VSEC
$3.44B
| $3.75M | 0.03% |
45,388
+3,240
| +8% | +$268K |
|
420
Lumentum
LITE
$10.4B
| $3.74M | 0.03% |
59,044
-298,496
| -83% | -$18.9M |
|
421
RingCentral
RNG
$2.89B
| $3.74M | 0.03% |
118,157
-10,358
| -8% | -$328K |
|
422
Warby Parker
WRBY
$3.17B
| $3.72M | 0.03% |
+227,645
| New | +$3.72M |
|
423
Wave Life Sciences
WVE
$1.32B
| $3.7M | 0.03% |
+451,813
| New | +$3.7M |
|
424
Esperion Therapeutics
ESPR
$540M
| $3.7M | 0.03% |
2,244,360
-2,805,448
| -56% | -$4.63M |
|
425
Aurinia Pharmaceuticals
AUPH
$1.63B
| $3.67M | 0.03% |
500,494
-113,572
| -18% | -$832K |
|